Cerebrovascular Diseases And Brain Ageing – A Program Of Research Into Novel Mechanisms, Risk Prevention And Innovative Health Care Delivery
Funder
National Health and Medical Research Council
Funding Amount
$466,492.00
Summary
This research is aimed at understanding the ways in which age-related vascular disease affecting the brain leads to walking difficulty, cognitive impairment and falls in older people. It is also designed to discover potentially modifiable risk factors for such vascular disease. Ultimately the goal of this research is to design and conduct trials of interventions aimed at slowing the process of vascular brain ageing.
The Influence Of Gender And Steroid Hormones On Cerebrovascular NADPH Oxidase During Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$390,974.00
Summary
My research addresses several major questions regarding the regulation of brain blood flow and mechanisms that may contribute to stroke. There is confusion as to whether giving menopausal women hormone replacement worsens the effect of having a stroke. I propose that female hormones may lower blood flow to the brain after menopause and therefore cause more damage to the brain after stroke.
The Role Of The Complement System In Neurodegeneration And The Therapeutic Potential Of Complement Inhibition
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
This project aims to identify the role of immune and inflammatory components in the pathology of neurodegenerative disease. Additionally, this research will determine whether a new class of novel anti-inflammatory drugs can alter the neurodegenerative process. This will allow for an increased understanding of the biology of neurodegenerative disease, and also may lead to the development of new treatments for conditions such as Parkinson’s disease, Huntington’s disease and motor neuron disease.
Investigatin The Causes Of Failed Efferocytosis In COPD-emphysema With A View To Identifying Novel Theraputic Targets
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
COPD is a leading cause of death. Smoking is the major cause of COPD and many sufferers are left with permanent damage and need ongoing treatment even after smoking cessation. Current treatments for COPD generally have limited efficacy. The project will identify the reason for the large number of dying cells and defective clearance of these cells that we have identified in the airways in COPD and study novel treatments that we hope will improve the health and well being of those with COPD.
Gene Discovery And Pathobiology In Muscle Diseases
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
I aim to find the genetic causes of muscle diseases that are lethal or severely debilitating. These diseases result in a significant burden to the affected individuals and their families and also on Australia’s Health care system. A genetic diagnosis provides families with answers, allows family planning, such that couples do not have another affected child, enables appropriate clinical management and gives researchers evidence as to how to develop treatments.